These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 3856469)
1. Chromosomal abnormalities in lymphoid crisis of chronic myelogenous leukemia. Yao E Cancer Genet Cytogenet; 1985 Apr; 16(3):235-43. PubMed ID: 3856469 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the expression of terminal deoxynucleotidyl transferase and common acute lymphoblastic leukemia antigen in selected hematologic malignancies. Bodner SM; Casavant CH; McHugh TM; Stites DP Diagn Immunol; 1985; 3(3):139-44. PubMed ID: 2932276 [TBL] [Abstract][Full Text] [Related]
3. Near-haploid cell line in the blastic crisis of chronic myelogenous leukemia: a possible marker for lymphoid malignancy. Najafzadeh TM; Dumars GE; Dumars KW; Simpkins H; Katz J Cancer Genet Cytogenet; 1983 Aug; 9(4):333-9. PubMed ID: 6603258 [TBL] [Abstract][Full Text] [Related]
4. Complex chromosomal abnormalities in a patient with lymphoid blast crisis of chronic myelogenous leukemia. Haubenstock A; Kim HJ; Zalusky R; Malamud SC; Mernick MH Am J Hematol; 1986 Aug; 22(4):435-7. PubMed ID: 3460329 [TBL] [Abstract][Full Text] [Related]
5. [Chromosome analysis and TdT determination: important prognostic parameters of blastic crises in chronic myelocytic leukemia]. Schwarzmeier JD; Haas O; Paietta E; Fischer P Wien Klin Wochenschr; 1982 Oct; 94(19):514-20. PubMed ID: 6760560 [TBL] [Abstract][Full Text] [Related]
6. Terminal deoxynucleotidyl transferase in the blastic phase of chronic myelogenous leukemia: an indicator of response to vincristine and prednisone therapy. Tanaka M; Kaneda T; Hirota Y; Yoshida S; Kitajima K Am J Hematol; 1980; 9(3):287-93. PubMed ID: 6940442 [TBL] [Abstract][Full Text] [Related]
8. Separation of lymphoid and myeloid blasts in the mixed blast crisis of chronic myelogenous leukemia: no evidence for Ig gene rearrangement in CALLA-positive blasts. Ha K; Freedman MH; Hrincu A; Petsche D; Poon A; Gelfand EW Blood; 1985 Dec; 66(6):1404-8. PubMed ID: 2415187 [TBL] [Abstract][Full Text] [Related]
9. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis. Shumak KH; Baker MA; Taub RN; Coleman MS Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237 [TBL] [Abstract][Full Text] [Related]
10. Phenotypic changes in a case of blast crisis of CML: characterization by TdT, cytochemistry, and cytogenetics. Paietta E; Schwarzmeier JD Scand J Haematol; 1981 Oct; 27(4):241-6. PubMed ID: 6955937 [TBL] [Abstract][Full Text] [Related]
11. Vincristine and prednisolone therapy in blast crisis of chronic myelogenous leukaemia in childhood. Kano Y; Takaku F; Sakamoto S; Hida K; Kasahara T; Okamura J; Hasegawa K; Tsukada T; Sasaki H Scand J Haematol; 1981 Nov; 27(5):323-6. PubMed ID: 6955938 [TBL] [Abstract][Full Text] [Related]
12. Clinical utility of terminal deoxynucleotidyl transferase and adenosine deaminase determinations in adult leukemia with a lymphoid phenotype. Brusamolino E; Isernia P; Lazzarino M; Scovassi I; Bertazzoni U; Bernasconi C J Clin Oncol; 1984 Aug; 2(8):871-80. PubMed ID: 6589363 [TBL] [Abstract][Full Text] [Related]
13. Dual expression of lymphoid/basophil markers on single blast cells transformed from chronic myeloid leukemia. Kuriyama K; Tomonaga M; Yao E; Soda H; Nonaka H; Jinnai I; Matsuo T; Yoshida Y; Amenomori T; Ichimaru M Leuk Res; 1986; 10(8):1015-24. PubMed ID: 3462436 [TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia. Paciucci PA; Keaveney C; Cuttner J; Holland JF Cancer Res; 1987 Oct; 47(19):5234-7. PubMed ID: 3476201 [TBL] [Abstract][Full Text] [Related]
15. Emergence of a cell line with extreme hypodiploidy in blast crisis of chronic myelocytic leukemia. Como RM; Graze PR Blood; 1979 Apr; 53(4):707-11. PubMed ID: 284783 [TBL] [Abstract][Full Text] [Related]
16. Characterisation of blast cells during blastic phase of chronic myeloid leukaemia by immunophenotyping--experience in 60 patients. Saikia T; Advani S; Dasgupta A; Ramakrishnan G; Nair C; Gladstone B; Kumar MS; Badrinath Y; Dhond S Leuk Res; 1988; 12(6):499-506. PubMed ID: 3165486 [TBL] [Abstract][Full Text] [Related]
17. t(1;2), inv(1) and trisomy 1q during the blastic phase of Philadelphia chromosome-positive chronic myeloid leukemia. Carbone P; Barbata G; Santoro A; Giglio MC; Mirto S; Granata G Acta Haematol; 1987; 77(4):198-202. PubMed ID: 3115029 [TBL] [Abstract][Full Text] [Related]
18. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia. Qing X; Qing A; Ji P; French SW; Mason H Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750 [TBL] [Abstract][Full Text] [Related]
19. Chromosomal anomaly of 6q in chronic myelogenous leukemia (CML). Srivastava AK; Gruppo RA; Siegrist CW Cancer Genet Cytogenet; 1981 Mar; 3(2):131-6. PubMed ID: 6944154 [TBL] [Abstract][Full Text] [Related]
20. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML]. Liu YL; Wang XN; Liu HS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]